Glezer Stanislav's Insider Trades & SAST Disclosures
Glezer Stanislav's most recent trade in Inogen Inc was a trade of 32,638 Common Stock done . Disclosure was reported to the exchange on May 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Glezer Stanislav.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 32,638 | 48,744 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 32,638 | 0 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.05 per share. | 01 May 2024 | 16,695 | 32,049 (0%) | 0% | 7.1 | 117,700 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 43,993 | 43,993 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 13,914 | 23,729 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 9,360 | 18,719 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.03 per share. | 01 Mar 2024 | 7,623 | 16,106 (0%) | 0% | 7.0 | 53,552 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 3,786 | 3,787 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, R&D & Chief Med. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 768 | 4,612 | - | - | Restricted Stock Unit | |
| Inogen Inc | Glezer Stanislav | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 4,555 | 12,146 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Glezer Stanislav | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 3,786 | 3,787 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 01 Dec 2023 | 2,331 | 9,815 (0%) | 0% | 5.7 | 13,333 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 769 | 5,380 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 768 | 7,609 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 768 | 6,918 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.37 per share. | 01 Jun 2023 | 393 | 7,216 (0%) | 0% | 10.4 | 4,075 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 28,079 | 28,079 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 4,556 | 9,409 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 3,787 | 7,573 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.56 per share. | 28 Feb 2023 | 2,568 | 6,841 (0%) | 0% | 15.6 | 39,958 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 2,272 | 5,995 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.56 per share. | 28 Feb 2023 | 1,142 | 4,853 (0%) | 0% | 15.6 | 17,770 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 769 | 7,686 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 4,555 | 6,054 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 3,787 | 7,573 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.89 per share. | 01 Dec 2022 | 2,331 | 3,723 (0%) | 0% | 22.9 | 53,357 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 768 | 8,455 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 3,075 | 9,223 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 3,075 | 3,075 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 01 Sep 2022 | 1,576 | 1,499 (0%) | 0% | 28.2 | 44,380 | Common Stock |
| Inogen Inc | Stanislav Glezer | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 32,638 | 32,638 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,360 | 11,360 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,360 | 11,360 | - | - | Restricted Stock Unit | |
| Inogen Inc | Stanislav Glezer | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2021 | 12,298 | 12,298 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges